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Introduction
Our study aims to compare the prevalence and geno-
types of HPV in HIV-positive and negative women in
Ouagadougou, where HIV and HPV prevalence are
respectively estimated at 4.0% and 24%.
Materials and methods
The study involved 410 women: 205 HIV-positive fol-
lowed by two sites of HIV/AIDS care in the eastern out-
skirts of Ouagadougou, matched by age with 205 HIV-
negative consulting the gynaecological services in the
same area. HPV genotyping was done by PCR followed
by reverse hybridization on nitrocellulose strips with the
kit “STAR HPV Blot” (Diatech
®, Italy).
Results
Prevalence of HPV was: 25.4% among HIV-negative
women and 59.0% among HIV-positive women (p
<0.01). Means of age was respectively 33.6 (SD±8.6) ver-
sus 33.4 (SD±6.4). Prevalence of HPV subtypes at low
risk of oncogenicity (6,11,LR) among HIV-positive
women was 9.8% and 9.3% in the control group (p=ns).
Prevalence of HPV subtypes at high risk of oncogenicity
was significantly(p<0.01) higher among HIV-positive
women for subtypes 50’S (22.0% versus 9.3%, OR=2.8 ;
CL95% 1.5-5.1), 18 (20.0% versus 2.9%, OR=8.3 ; CL95%
3.2–23.0), 30’S (17.6% versus 1.5%, OR=14.3 ; CL95%
4.1–60.1) and HR ( 7.3%, versus 1.0%, OR=8.0 ; CL95%
1.7–52.1) while no significant difference was observed
for high risk subtypes 16 and 45. Co-infections by two
or more subtypes at high risk were detected in 27/205
(13.2%) HIV-positive women and 3/205 (1.5%) HIV-
negative women (p<0.01; OR 10.2; CL95% 2.9-43.5).
Among HIV-positive women, prevalence of oncogenic
subtypes was significantlycorrelated with a lower CD4
count (P = 0.05).
Conclusions
HIV-positive women are at high risk of coinfection by
HPV oncogenic subtypes. This study confirms the need
to integrate the screening of cervical cancer in HIV care
protocols in Burkina Faso. Further investigations should
be continued for the establishment of vaccine that
matches all genotypes circulating in the country.
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